Total Payments
$613,095
2024 Payments
$1,549
Companies
19
Transactions
420
Payment Breakdown by Category
Consulting$408,281 (66.6%)
Travel$149,628 (24.4%)
Other$42,314 (6.9%)
Food & Beverage$9,104 (1.5%)
Research$3,750 (0.6%)
Education$18.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $408,281 | 93 | 66.6% |
| Travel and Lodging | $149,628 | 128 | 24.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,314 | 25 | 6.9% |
| Food and Beverage | $9,104 | 171 | 1.5% |
| Unspecified | $3,750 | 2 | 0.6% |
| Education | $18.00 | 1 | 0.0% |
Payments by Type
General
$609,345
418 transactions
Research
$3,750
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $124,937 | 81 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $103,285 | 92 | $0 (2024) |
| GENZYME CORPORATION | $95,558 | 37 | $0 (2024) |
| AstraZeneca UK Limited | $85,616 | 79 | $0 (2023) |
| GlaxoSmithKline, LLC. | $68,495 | 60 | $0 (2023) |
| Novartis Pharma AG | $38,729 | 12 | $0 (2019) |
| ALK-Abello, Inc | $23,005 | 10 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $13,429 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $11,113 | 6 | $0 (2021) |
| Boehringer Ingelheim International GmbH | $9,340 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,549 | 4 | AstraZeneca Pharmaceuticals LP ($1,435) |
| 2023 | $9,724 | 7 | GENZYME CORPORATION ($3,756) |
| 2022 | $54,629 | 17 | GENZYME CORPORATION ($35,675) |
| 2021 | $18,635 | 8 | AstraZeneca AB ($8,861) |
| 2020 | $58,155 | 22 | AstraZeneca UK Limited ($20,240) |
| 2019 | $217,320 | 144 | AstraZeneca UK Limited ($61,236) |
| 2018 | $135,953 | 115 | Regeneron Healthcare Solutions, Inc. ($36,543) |
| 2017 | $117,128 | 103 | AstraZeneca Pharmaceuticals LP ($39,517) |
All Payment Transactions
420 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/02/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,342.50 | General |
| 05/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $113.40 | General |
| Category: Immunology | ||||||
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $42.94 | General |
| Category: Respiratory | ||||||
| 05/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $49.95 | General |
| Category: Respiratory | ||||||
| 09/11/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $351.00 | General |
| 08/01/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Respiratory | ||||||
| 06/05/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,404.70 | General |
| 05/20/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $57.20 | General |
| Category: Respiratory | ||||||
| 05/19/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.52 | General |
| 02/14/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $3,087.75 | General |
| 01/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2022 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $428.23 | General |
| 12/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $14,941.00 | General |
| Category: Immunology | ||||||
| 12/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $9,234.00 | General |
| Category: Immunology | ||||||
| 12/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $220.00 | General |
| Category: Immunology | ||||||
| 12/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.00 | General |
| Category: Immunology | ||||||
| 12/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Immunology | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| 09/15/2022 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,112.00 | General |
| Category: Immunology | ||||||
| 08/22/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Education | In-kind items and services | $18.00 | General |
| Category: Respiratory | ||||||
| 07/12/2022 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,425.00 | General |
| 06/23/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,564.00 | General |
| Category: Immunology | ||||||
| 05/29/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $3,222.00 | General |
| 05/16/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $4,404.00 | General |
| Category: Immunology | ||||||
| 05/14/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,240.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $3,214 | 1 |
| LONG TERM NATURAL HISTORY OF PATIENTS WITH SEVERE OR DIFFICULT TO TREAT ASTHMA FROM THE TENOR OBSERVATIONAL STUDY | Novartis Pharmaceuticals Corporation | $536.00 | 1 |
About Dr. Eugene Bleecker, MD
Dr. Eugene Bleecker, MD is a Critical Care Medicine healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811971104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Bleecker, MD has received a total of $613,095 in payments from pharmaceutical and medical device companies, with $1,549 received in 2024. These payments were reported across 420 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($408,281).
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Winston Salem, NC
- Active Since 12/01/2005
- Last Updated 01/07/2008
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1811971104
Products in Payments
- DUPIXENT (Biological) $112,010
- DUPIXENT DUPILUMAB INJECTION (Biological) $69,540
- DUPIXENT (Drug) $51,783
- FASENRA (Drug) $41,494
- IGE025A (Biological) $30,361
- Odactra (Drug) $23,005
- NUCALA (Biological) $21,621
- SPIRIVA RESPIMAT (Drug) $10,769
- IGE025A_XOLAIR _RESPIRATORY (Biological) $8,368
- SPIRIVA (Drug) $5,182
- XOLAIR (Biological) $3,797
- AIRSUPRA (Drug) $2,248
- SYMBICORT (Drug) $1,556
- FASENRA (Biological) $1,480
- BEVESPI AEROSPHERE (Drug) $192.18
- Esbriet (Biological) $116.85
- ASTHMA - DISEASE (Drug) $65.95
- GENERAL BRONCHIAL THERMOPLASTY (Device) $58.68
- TEZSPIRE (Biological) $49.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Winston Salem
Dr. Ashish Khanna, M.d, M.D
Critical Care Medicine — Payments: $555,153
Critical Care Medicine $555,153
Wendy Moore, Md, MD
Critical Care Medicine — Payments: $78,662
Critical Care Medicine $78,662
Dr. Chad Marion, Do, DO
Critical Care Medicine — Payments: $20,364
Critical Care Medicine $20,364
Gregory Ross, Md, MD
Critical Care Medicine — Payments: $12,457
Critical Care Medicine $12,457
Thomas Hinson, Md, MD
Critical Care Medicine — Payments: $10,347
Critical Care Medicine $10,347
Dr. Casey Bryant, M.d, M.D
Critical Care Medicine — Payments: $5,031
Critical Care Medicine $5,031